The overlap in clinical and magnetic resonance imaging (MRI) findings between Alzheimer’s disease and glaucoma.
China NMPA accepts Junshi’s sNDA for toripalimab
The sNDA is based on the results of the MELATORCH study in patients with unresectable or metastatic melanoma. Credit: Gorodenkoff/Shutterstock. The China National Medical Products